Each year, more than 115,000 women in the United States are diagnosed with gynecologic cancers, which include ovarian, uterine, cervical, vaginal, and vulvar cancers. Despite their prevalence, awareness of these cancers remains limited, partly due to cultural barriers and the sensitive nature of symptoms related to the female reproductive system, experts say.
Matthew A. Powell, M.D., president of the Society of Gynecologic Oncology (SGO), emphasized the importance of recognizing early warning signs. Irregular bleeding, particularly postmenopausal bleeding, warrants medical evaluation, as does abnormal bleeding between periods or after sexual intercourse. While such symptoms do not always indicate cancer, timely assessment by a healthcare provider is essential. Other symptoms, such as persistent changes in bowel or bladder habits, may signal ovarian or fallopian tube cancer and are often mistaken for gastrointestinal issues. For vulvar and vaginal cancers, patients should monitor for skin changes or unusual growths in the genital area.
Medical professionals recommend that individuals experiencing concerning or persistent symptoms begin evaluation with a primary care physician or an obstetrician-gynecologist. If symptoms continue or require specialized attention, referral to a gynecologic oncologist, who has advanced training in these cancers, may be necessary.
Risk factors vary among the different types of gynecologic cancers. Family history plays a significant role in ovarian and fallopian tube cancers, especially if close relatives have had breast, ovarian, or fallopian tube cancer. Uterine cancer risk is influenced by factors such as irregular menstrual cycles, diabetes, overweight status, and hormonal imbalances. Human papillomavirus (HPV) infection is the primary risk factor for cervical cancer, and vaccination against HPV is highly effective in preventing most cervical cancers and their precursors.
Recent advances in both prevention and treatment offer new hope. Research has identified that many ovarian cancers begin in the fallopian tubes, leading to recommendations that women consider removal of fallopian tubes after completing childbearing to lower cancer risk. This procedure allows the ovaries to be preserved, thus avoiding early menopause. While treatments for metastatic cancer have improved significantly, the ultimate goal remains cancer prevention and earlier detection.
The Society of Gynecologic Oncology, with over 2,500 members, plays a critical role in advancing research, clinical care, and education. Through clinical trials and training programs, SGO equips healthcare providers with the latest knowledge and supports patients in understanding treatment options, including the benefits and process of clinical trial participation.
Dr. Powell noted that many women seek care only after enduring prolonged symptoms, underscoring the need for greater public awareness and open discussions about gynecologic health. Enhanced education and early diagnosis are vital steps toward reducing the burden of these cancers and improving outcomes for patients nationwide.